We recently spoke with Nikole Kimes, PhD, CEO and Co-Founder at Siolta Therapeutics, a clinical-stage biopharmaceutical company developing targeted microbiome-based therapeutics to prevent and treat diseases of high unmet medical need.
Its lead program, STMC-103H is currently in phase 2 development to prevent...